MindMed
phase trial of utilized standard gad design and and was aligned with draft guidance for drug class class | MindMed
Company
Deck Type
Sector
Industry
Deck date
December 2024
Slide
28 of 42
Similar slides by MindMed
See diffirences between slides (animation)
Investor Presentation
November 2024
phase trial of utilized standard gad design and and was aligned with draft guidance for drug class class | MindMed
Related slides by other companies
Aeglea BioTherapeutics
Investor Presentation
August 2020
pivotal phase peace trial design | Aeglea BioTherapeutics
Aeglea BioTherapeutics
Investor Presentation
June 2020
pivotal phase peace trial design | Aeglea BioTherapeutics
Aeglea BioTherapeutics
Investor Presentation
May 2023
phase clinical trial design | Aeglea BioTherapeutics
ATAI
Investor Conference
May 2023
phase trial design randomized week study of and placebo in patients with | ATAI
Other recent decks by MindMed
See all presentations (10 decks)
Investor Presentation
January 2025
Investor Presentation
November 2024
Results
November 2023
Investor Presentation
September 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io